When cancer cells were treated first with MLE at 0.1 μg/mL (for 4 h) and then dacarbazine was added and incubation was continued for 48 h, the activity of caspase-3 was c.a. 2.5-fold higher as compared to untreated cells. This evidence concerns the gene CASP3 and cancer.